Intraoperative Neuromonitoring Market Report 2025

The intraoperative neuromonitoring market size has grown strongly in recent years. It will grow from $3.56 billion in 2024 to $3.8 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to rising incidence of neurological disorders, growing awareness among surgeons, expanding applications in various surgeries, increasing geriatric population, insurance coverage and reimbursement policies.

The intraoperative neuromonitoring market size is expected to see strong growth in the next few years. It will grow to $5.23 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing demand for minimally invasive surgeries, global surge in surgical procedures, growing focus on patient safety, expanding applications in new medical fields, government initiatives and regulations. Major trends in the forecast period include technological advancements, IoT-based devices, product innovations, strategic collaborations.

Anticipated growth in the intraoperative neuromonitoring market is driven by the escalating prevalence of neurovascular disorders. These disorders, spanning conditions like Parkinson's disease, Alzheimer's disease, and epilepsy, are chronic in nature. Intraoperative neuromonitoring plays a pivotal role in evaluating neural structure integrity and consciousness during surgeries related to various neurological diseases, including Alzheimer's. Notably, projections from the National Library of Medicine suggest a rise in Alzheimer's cases among Americans aged 65 and above, reaching an estimated 13.8 million by 2060 from the current 6.2 million, underscoring the significance of addressing the surge in chronic ailments for the growth of this market.

The burgeoning demand for early health issue detection is poised to propel the intraoperative neuromonitoring market. Timely diagnosis relies heavily on precise and highly accurate diagnostic tools. Manufacturers in this sector constantly innovate to bolster tool precision, meeting the need for early and dependable diagnosis. For instance, the King's Fund reported a noticeable surge in diagnostic demand post the COVID-19 pandemic. Figures indicate a 15% rise in patients awaiting diagnostic tests in January 2023 compared to the prior decade, and a 10% increase from the previous year. This escalating demand for early health issue detection is expected to positively influence the intraoperative neuromonitoring market during the forecast period.

The adoption of technologically advanced devices in intraoperative neuromonitoring is a significant trend gaining traction in the intraoperative neuromonitoring market. Leading companies in this sector are dedicated to developing innovative technological solutions to enhance their competitive edge. For example, in October 2023, Nihon Kohden, a Japan-based medical device manufacturer, launched the One View solution. This advanced feature is part of the Neuromaster G1 intraoperative neuromonitoring (IONM) system. It enables seamless integration of a patient’s anesthesia and vital signs - such as heart rate, SpO2, and temperature - with neurological data within the IONM software. The solution incorporates a customizable pop-up notification system that includes auditory cues, facilitating quick responses and timely interventions. These notifications can be programmed to activate based on predefined threshold parameters.

Noteworthy advancements in brain-machine interface technology have become a focal point for major players in the intraoperative neuromonitoring market. Companies are concentrating efforts on introducing groundbreaking brain-machine interface technology to expand their service portfolios and drive revenue growth. Axoft, a US-based neurotechnology company, attained FDA Breakthrough Device designation for its brain-machine interface (BMI) technology in October 2022. This technology aims to improve the quality of life for individuals grappling with neurological disorders by providing better therapeutic options and potentially mitigating the severity of symptoms.

In March 2024, MPOWERHealth, a US-based provider of intraoperative neuromonitoring solutions, acquired Assure Neuromonitoring for an undisclosed amount. The acquisition aims to strategically enhance MPOWERHealth's presence in key markets and expand access to its intraoperative neuromonitoring (IONM) services. This integration is designed to improve operational efficiency and support healthcare providers, ultimately strengthening patient safety during surgeries. Assure Neuromonitoring is also a US-based company that offers intraoperative neuromonitoring services.

Major companies operating in the intraoperative neuromonitoring market are Medtronic PLC, Natus Medical Incorporated, Cadwell Industries Inc., Siemens Healthineers, Neurosign, Mizuho Medical Co. Ltd., EEG Solutions Inc., Invenia Technical Computing, Cablescope Inc., Blackrock Neurotech, Specialty Surgical Instrumentation, NeuroWave Systems, Intraoperative Monitoring Services LLC, BrainScope Company, Inc., Trident Medical Inc., CortiCare, Soterix Medical, Viking Medical, Neuromonitoring Associates, NeuroVigil, Neurophysiology Associates, NeuroDiagnostic Institute, Biomedical Monitoring Inc., The EPI Group, Advanced Neuromonitoring Technologies, Amplified NeuroTech.

North America was the largest region in the intraoperative neuromonitoring market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intraoperative neuromonitoring market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the intraoperative neuromonitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Intraoperative neuromonitoring refers to a set of techniques employed during high-risk surgeries involving the nervous system, orthopedics, peripheral nerves, and vascular procedures. It enables real-time monitoring of critical brain structures, empowering surgeons to identify and prevent potential neural damage.

The primary offerings within intraoperative neuromonitoring encompass systems, accessories, and services. Systems represent an amalgamation of components working toward a shared objective. Diverse modalities such as motor-evoked potentials, somatosensory evoked potentials, electroencephalography, electromyography, brainstem auditory evoked potentials, and visual-evoked potentials are utilized across spinal surgery, neurosurgery, vascular surgery, ENT surgery, orthopedic surgery, and other medical domains. These solutions find application in hospitals and ambulatory surgical centers.

The intraoperative neuromonitoring market research report is one of a series of new reports that provides intraoperative neuromonitoring market statistics, including the intraoperative neuromonitoring industry’s global market size, regional shares, competitors with an intraoperative neuromonitoring market share, detailed intraoperative neuromonitoring market segments, market trends and opportunities, and any further data you may need to thrive in the intraoperative neuromonitoring industry. This intraoperative neuromonitoring market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The intraoperative neuromonitoring mainly includes revenues earned by entities by providing neuro services such as insourced monitoring and outsourced monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.